JPH02150240A - Chewing gum - Google Patents
Chewing gumInfo
- Publication number
- JPH02150240A JPH02150240A JP63302777A JP30277788A JPH02150240A JP H02150240 A JPH02150240 A JP H02150240A JP 63302777 A JP63302777 A JP 63302777A JP 30277788 A JP30277788 A JP 30277788A JP H02150240 A JPH02150240 A JP H02150240A
- Authority
- JP
- Japan
- Prior art keywords
- gum
- lactulose
- chewing gum
- sweetener
- constipation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015218 chewing gum Nutrition 0.000 title claims abstract description 8
- 229940112822 chewing gum Drugs 0.000 title claims abstract description 7
- JCQLYHFGKNRPGE-WJONTELPSA-N (2s,3r,4s,5r,6r)-2-[(2r,3s,4s,5s)-4,5-dihydroxy-2,5-bis(hydroxymethyl)oxolan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound OC[C@H]1O[C@@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-WJONTELPSA-N 0.000 claims abstract 3
- 206010010774 Constipation Diseases 0.000 abstract description 10
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 abstract description 8
- 235000003599 food sweetener Nutrition 0.000 abstract description 5
- 239000003765 sweetening agent Substances 0.000 abstract description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 abstract description 4
- 208000002925 dental caries Diseases 0.000 abstract description 4
- 239000006188 syrup Substances 0.000 abstract description 3
- 235000020357 syrup Nutrition 0.000 abstract description 3
- 241000894006 Bacteria Species 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- 208000008589 Obesity Diseases 0.000 abstract description 2
- 229920002472 Starch Polymers 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 235000020824 obesity Nutrition 0.000 abstract description 2
- 239000008107 starch Substances 0.000 abstract description 2
- 235000019698 starch Nutrition 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000019634 flavors Nutrition 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 15
- 229960000511 lactulose Drugs 0.000 description 15
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 15
- 230000000694 effects Effects 0.000 description 7
- 241000186000 Bifidobacterium Species 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 4
- 230000013872 defecation Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000004169 Hydrogenated Poly-1-Decene Substances 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000019383 crystalline wax Nutrition 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013350 formula milk Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000010985 glycerol esters of wood rosin Nutrition 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 229940125722 laxative agent Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- JLQFVGYYVXALAG-CFEVTAHFSA-N yasmin 28 Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1.C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 JLQFVGYYVXALAG-CFEVTAHFSA-N 0.000 description 1
Landscapes
- Confectionery (AREA)
- Seasonings (AREA)
Abstract
Description
【発明の詳細な説明】
（産業上の利用分野）
本発明は、４−０−β−Ｄ−ガラクトピラノシルーα−
Ｄ−フラクトース（以）ラクチュロースと記載する）を
含有するチューインガムに関する。Detailed Description of the Invention (Industrial Field of Application) The present invention provides 4-0-β-D-galactopyranosyl α-
The present invention relates to a chewing gum containing D-fructose (hereinafter referred to as lactulose).
［従来技術１
従来、チューインガムは虫歯予防のため甘味料として砂
糖を使用しないタイプ、日本人に不足しているカルシウ
ムを強化したタイプ、あるいは口臭予防を目的として種
々の物質を添加したタイプ等が開発され、市販されてい
る。[Prior art 1] In the past, chewing gums have been developed such as types that do not use sugar as a sweetener to prevent tooth decay, types that are fortified with calcium, which Japanese people lack, and types that have various substances added to prevent bad breath. and is commercially available.
一方うクヂ１０−スはビフィズス菌発育促進作用をａ
することから乳幼児用調製粉乳に使用され、血中のアン
［２７１度を低下する作用を有することから肝竹脳症治
療剤として市販され、更に便秘に有効であることがら便
秘治療剤としても市販されている。On the other hand, Quji 10-su has the effect of promoting the growth of bifidobacteria.
Because of this, it is used in formula milk for infants, and because it has the effect of lowering blood levels of 271 degrees Celsius, it is marketed as a treatment for hepatic encephalopathy. Furthermore, because it is effective for constipation, it is also marketed as a treatment for constipation. ing.
［発明が解決しようとする問題点］
近年、我国において若い女性に便秘あるいは便秘気味の
人が多いことは知られている。また、若い女性であるこ
とから肥る要因となる［１味食品を敬遠する傾向にある
。[Problems to be solved by the invention] It is known that in recent years in our country, many young women are suffering from constipation or a tendency to constipation. Also, because she is a young woman, she tends to avoid single-tasting foods, which can make her fat.
本発明は、ラクチュロースをヂ、１−インガムに用いる
ことにより、ノン力【］り一甘せ料としての効果、便秘
予防（または改善）の効果及び腸内ビフィズス菌増殖の
効果を企図したものである。The present invention aims to use lactulose in di-1-ing gum to have an effect as a non-potent sweetener, an effect to prevent (or improve) constipation, and an effect to increase intestinal bifidobacterium proliferation. be.
［発明の構成］
本発明に使用するラクチュロ−スは公知の方法（例えば
特許第８７４９５４号等）で製造されたラクチュロース
含有シ［１ツブであり、可及的にラクチュ【］−ス含績
が高いものであることが望ましい。また必要に応じて公
知の方法（例えば特許第７７８５６５号等）で粉末化し
たラクチュロースを単独でまたはシクチュ［１−スジ【
］ツブと併用して使用することもできる。[Structure of the Invention] The lactulose used in the present invention is a lactulose-containing syrup produced by a known method (for example, Patent No. 874954, etc.), and the lactulose content is as low as possible. It is desirable that it be high. In addition, if necessary, lactulose powdered by a known method (for example, Japanese Patent No. 778565) may be used alone or in
] Can also be used in combination with whelk.
本発明のチューインガムは公知の方法によって製造する
ことができる。通常のヂコーインガム製造にお４Ｊる配
合の−・例を示Ｕば、２２％のガムベース、 １％の香
料、 ２％の炭酸カルシウム。The chewing gum of the present invention can be manufactured by a known method. Here is an example of the 4J formulations used in the production of regular dicoing gum: 22% gum base, 1% flavoring, 2% calcium carbonate.
そして糖類として粉糖４０χ、ブドウ糖２０％、水あめ
１５％である。本発明においては上記の糖類の一部また
は全部を粉末状及び（または）シロップ状のラクチュロ
ースで置換することができる。The sugars are 40x powdered sugar, 20% glucose, and 15% starch syrup. In the present invention, part or all of the above sugars can be replaced with powdered and/or syrupy lactulose.
次に試験例を示して本発明を詳述する。Next, the present invention will be explained in detail by showing test examples.
（試験例１）
実施例１と同一の方法により製造したラクチュロースを
含有Ｊるデユーインガムを２０才から２７オまでの便秘
気味（毎［１規則的な排便がなく、２〜３［］に−・度
排便する）の女性２０人に１日５枚ずつ１０日間試食さ
ゼた。その結果１７人に毎日規則的な排便が認められた
。(Test Example 1) Dewing gum containing lactulose produced by the same method as in Example 1 was administered to patients aged 20 to 27 with constipation (every [1: no regular defecation, 2 to 3 []). Twenty women with frequent defecations were given five slices a day for 10 days. As a result, 17 people were found to have regular defecation every day.
（試験例２）
試験例１の実施前及び実痛１０日目の全員の便の細菌叢
を公知の方法で測定し、ラクチュロース含有チＩＬ−イ
ンガム試食前後の細菌叢の変化を調査した。その結果は
数表のとおりであった。(Test Example 2) The bacterial flora of the feces of all participants before the implementation of Test Example 1 and on the 10th day of actual pain was measured by a known method, and changes in the bacterial flora before and after tasting the lactulose-containing IL-ingum gum were investigated. The results were as shown in the table.
以 下 余 白
表１
表１から明らかなように、試食者２０名の平均値として
、総画数に占めるビフィズス菌の比率が顕著に増加した
。なお、ビフィズス菌比率の増加傾向は、試食者２０名
中１９名に認められ、便秘が改善された１７名中１５名
においてその傾向は顕著であった。As is clear from Table 1, the ratio of bifidobacteria to the total number of strokes increased significantly as an average value for the 20 tasters. Incidentally, an increasing tendency in the proportion of bifidobacteria was observed in 19 out of 20 tasters, and this tendency was remarkable in 15 out of 17 people whose constipation was improved.
実施例１ 酢酸ビニール樹脂２５０ｇ、チクルガム１２０ＳＪ。Example 1 250g of vinyl acetate resin, 120SJ of chicle gum.
ポリイソブチレン５０ｇ、マイク１１クリスタリンワツ
クス２５ｇ、乳化剤５ｓ＃および炭酸カルシウム５０ｔ
Ｊを１２０℃で加熱溶融し、混押し、次いでラクチュロ
ース含ｍ ９６％のラクチュロース粉末１６９０９１ハ
ーブエキス４５９および香料１５ｔＪを添加し、撹拌し
、均一化し、のち縦・横・厚みが１８ｘ７０ｘ ２ｍ、
重さ３ｇで成型し、冷却し、１枚当りラクチュロースを
２．２９含有す、る板状チューインガムを製造した。50g polyisobutylene, 25g Mike 11 crystalline wax, 5s# emulsifier and 50t calcium carbonate
Heat-melt J at 120°C, mix and press, then add lactulose powder 169091 herbal extract 459 containing 96% lactulose and 15tJ of fragrance, stir and homogenize.
The product was molded to a weight of 3 g and cooled to produce a plate-shaped chewing gum containing 2.29 lactulose per piece.
実施例２ グラフト重合体２４７９．エステルガム７４ｇ。Example 2 Graft polymer 2479. 74g of ester gum.
ワックス５０ｇ、可塑剤４５Ｊ、乳化剤５ｇおよび炭酸
カルシラｂ７４９を１２０℃で加熱溶融し、混捏（）、
次いでラクチュロース含ｆｉｉ９Ｇχのラクチュロース
粉末１４６３！１７ 、ラフチーｒ ＩＩ −ス含ｆｆ
１５２％のラクヂコ」１−スシロツプ（固形分含量７０
χ）２２５ｇ、炭酸カルシウム４５ｇ、およびニツキ香
料２２Ｌｊを添加し、撹拌均一化した後、縦・横・厚さ
が１３ｘ ３６ｘ ３．５Ｍ２重さ２９で成型し、冷即
し、１枚当りラクチュ（］−スを １．３５９含有する
板状チートーインガムを製造した。50g of wax, 45J of plasticizer, 5g of emulsifier and Calcilla carbonate B749 were heated and melted at 120°C, kneaded (),
Next, lactulose-containing fii9Gχ lactulose powder 1463!17, lactulose-containing fii9Gχ-containing ff
152% Rakujiko” 1-Sushiropp (solid content 70
After adding 225 g of χ), 45 g of calcium carbonate, and 22 Lj of Nikki fragrance, and stirring to make it uniform, it was molded into a piece measuring 13 x 36 x 3.5 M2 in length, width, and thickness, and weighing 29 mm. ] - A plate-shaped Cheeto Ingum containing 1.359 ml of -su was produced.
［発明の効果］ 本発明によって奏せられる効果は次のとおりである。[Effect of the invention] The effects achieved by the present invention are as follows.
■便秘または便秘気味の人に毎日規則的な排便もたら１
゜
■腸内ビフィズス菌の増殖をもたらす。■ Providing regular bowel movements every day for people with constipation or constipation 1
゜■Causes the proliferation of intestinal bifidobacteria.
■ラクチユロースは吸収されないので力ＩＩリ−として
利用されない。従って、肥満等の心配がない。■Lactylose is not absorbed, so it is not used as a force II. Therefore, there is no need to worry about obesity.
■ラクチス１コースはストレプトコッカス・ミュータン
ス等虫歯の発生に関与するといわれている細菌に利用さ
れ難いので、虫歯の発生が少ない。■Lactis 1 course is less likely to be used by bacteria such as Streptococcus mutans, which are said to be involved in the development of tooth decay, so there is little chance of tooth decay.
■便秘薬を購入し、服用するという精神的抵抗感を与え
ずに、気軽に常用させることができる。■You can easily make people use laxatives regularly without creating any mental resistance to purchasing and taking them.
Claims (1)
トースを含有することを特徴とするチューインガム。A chewing gum characterized by containing 4-O-β-D-galactopyranosyl-α-D-fructose.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63302777A JPH02150240A (en) | 1988-11-29 | 1988-11-29 | Chewing gum |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63302777A JPH02150240A (en) | 1988-11-29 | 1988-11-29 | Chewing gum |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH02150240A true JPH02150240A (en) | 1990-06-08 |
Family
ID=17912997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP63302777A Pending JPH02150240A (en) | 1988-11-29 | 1988-11-29 | Chewing gum |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH02150240A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994025002A1 (en) * | 1993-05-04 | 1994-11-10 | Bolder Arzneimittel Gmbh | Lactulose lozenges |
-
1988
- 1988-11-29 JP JP63302777A patent/JPH02150240A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994025002A1 (en) * | 1993-05-04 | 1994-11-10 | Bolder Arzneimittel Gmbh | Lactulose lozenges |
| US5688521A (en) * | 1993-05-04 | 1997-11-18 | Bolder Arzneimittel Gmbh | Lactulose pastilles |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8287897B2 (en) | Bitterness-masking particulate jelly beverage | |
| BRPI0712006A2 (en) | compositions that cause tingling and salivation | |
| JP2009530326A (en) | Functional food for tumors | |
| JP3381010B2 (en) | Fermented product containing propolis extract, production method and use thereof | |
| KR20190141707A (en) | Taken microbial group promoting composition and use thereof | |
| Van Houte et al. | Streptococcus mutans in the mouths of children with congenital sucrase deficiency | |
| JPS61171423A (en) | Drug for alleviating dental caries and periodontosis | |
| JP2018024619A (en) | Endurance improver | |
| JPH02150240A (en) | Chewing gum | |
| WO2016031292A1 (en) | Additive for orally administered composition | |
| JPH0649643B2 (en) | Formulations effective against bad breath | |
| JP2002220332A (en) | Gum for training in dentistry | |
| JP2019052186A (en) | Oral composition | |
| US20210007980A1 (en) | Use of enzyme-modified isoquercitrin | |
| JP2731948B2 (en) | New oligosaccharides and their production and use | |
| Maguire | Dental health | |
| JP3656972B2 (en) | Alcohol smell reducing agent | |
| CN109699801A (en) | A kind of functional Sugar Alcohol fruit and preparation method thereof | |
| JP7545018B2 (en) | High-protein food composition for promoting chewing and saliva secretion | |
| JP2009286749A (en) | Solid material for oral cavity hygiene | |
| Nagsuwanchart et al. | Mogroside, palatinose, erythritol, and xylitol differentially affect dental plaque pH in caries-active and caries-free children: an in vitro study | |
| JP4422960B2 (en) | β-maltose hydrous crystal-containing powder, its production method and use | |
| JP2004517921A (en) | Swallowing difficulty test agent | |
| JPH0367560A (en) | Sweetener composition | |
| JP6873668B2 (en) | Additives for oral compositions |